Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (48)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rudge, P.
Right arrow Articles by Hyman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rudge, P.
Right arrow Articles by Hyman, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 119, No. 1, 1-15, 1996
© 1996 Oxford University Press


research-article

Encephalomyelitis in primary hypogammaglobulinaemia

P. Rudge1,, A. D. B. Webster2, T. Revesz1, T. Warner1, T. Espanol4, C. Cunningham-Rundles5 and N. Hyman3

1Institute of Neurology, National Hospital for Neurology and Neurosurgery London 2Department of Clinical Immunology, Royal Free Hospital School of Medicine London 3Neurology Department, Battle Hospital Reading, UK 4Ciutat Sanitària i Universitaria, Vall d'Hebron Barcelona, Spain 5Mount Sinai School of Medicine, Mount Sinai Hospital New York, USA

Correspondence to: Dr P. Rudge, Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WCIN 3BG, UK

The neurological features of 13 patients with primary hypogammaglobulinaemia are described. Seven patients had X-linked agammaglobulinaemia (XLA) and six had common variable immunodeficiency (CVID). Three clinical pictures emerged: (i) a progressive myelopathy (one case); (ii) a myelopathy progressing to an encephalopathy (four cases); (iii) a pure encephalopathy (eight cases). In four patients the encephalopathy was temporarily reversible; the relationship of this to immunoglobulin therapy is unclear. Additional features occurred in some patients. Three had a retinopathy interpreted as retinitis pigmentosa, in one of whom the retinopathy resolved. Two patients had a sensori-neural hearing loss and three had features of dermatomyositis; a variable pleocytosis was found in the CSF of nine patients. Imaging revealed atrophic changes in the cerebral hemispheres in eight cases. Ten patients have died, 1–11 years after the onset of the CNS manifestations, and in four autopsies were obtained. Two patients had an encephalopathy, one with XLA had evidence of end-stage encephalitis and the other with CVID had a multi-focal leucoencephalopathy. The other two with XLA had leptomeningitis without evidence of encephalitis. Enteroviral infection is probably an important cause of neurological disease in these patients as CSF from seven patients was either positive by polymerase chain reaction (PCR) or by culture for enteroviruses. Other possible mechanisms are discussed.

encephalomyelitis; myositis; deafness; primary hypogammaglobulinaemia; enteroviral infection

Received May 25, 1995. Revised July 19, 1995. Accepted August 23, 1995.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch Otolaryngol Head Neck SurgHome page
L. Kainulainen, J. Suonpaa, J. Nikoskelainen, E. Svedstrom, T. Vuorinen, O. Meurman, and O. Ruuskanen
Bacteria and Viruses in Maxillary Sinuses of Patients With Primary Hypogammaglobulinemia
Arch Otolaryngol Head Neck Surg, June 1, 2007; 133(6): 597 - 602.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
D. R. Chadwick
Viral meningitis
Br. Med. Bull., February 10, 2006; 75-76(1): 1 - 14.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. Hollander, P. W. Schaefer, and E. T. Hedley-Whyte
Case 22-2005 - An 81-Year-Old Man with Cough, Fever, and Altered Mental Status
N. Engl. J. Med., July 21, 2005; 353(3): 287 - 295.
[Full Text] [PDF]


Home page
NeurologyHome page
M. D. Snyder, G. A. Storch, and D. B. Clifford
Atypical PML leading to a diagnosis of common variable immunodeficiency
Neurology, May 10, 2005; 64(9): 1661 - 1661.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
C G Vinuesa, C de Lucas, and M C Cook
Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens
Postgrad. Med. J., September 1, 2001; 77(911): 562 - 569.
[Full Text] [PDF]


Home page
J. Virol.Home page
P. P. Sanna and D. R. Burton
Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene Knockouts
J. Virol., November 1, 2000; 74(21): 9813 - 9817.
[Full Text]


Home page
Antimicrob. Agents Chemother.Home page
D. C. Pevear, T. M. Tull, M. E. Seipel, and J. M. Groarke
Activity of Pleconaril against Enteroviruses
Antimicrob. Agents Chemother., September 1, 1999; 43(9): 2109 - 2115.
[Abstract] [Full Text]


Home page
NeurologyHome page
M. Samuel, S.C.R. Williams, P. N. Leigh, A. Simmons, S. Chakraborti, C. M. Andrew, K. J. Friston, L. H. Goldstein, and D. J. Brooks
Exploring the temporal nature of hemodynamic responses of cortical motor areas using functional MRI
Neurology, December 1, 1998; 51(6): 1567 - 1575.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. D. Weiss, C. A. Luciano, C. Semino-Mora, M. C. Dalakas, and R. H. Quarles
Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma
Neurology, December 1, 1998; 51(6): 1738 - 1741.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. F. Hahn
Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Intravenous Immunoglobulin
Neurology, December 1, 1998; 51(6_Suppl_5): S16 - S21.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. C. Dalakas
Controlled Studies with High-Dose Intravenous Immunoglobulin in the Treatment of Dermatomyositis, Inclusion Body Myositis, and Polymyositis
Neurology, December 1, 1998; 51(6_Suppl_5): S37 - S45.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. L. Miller, J. Cummings, F. Mishkin, K. Boone, F. Prince, M. Ponton, and C. Cotman
Emergence of artistic talent in frontotemporal dementia
Neurology, October 1, 1998; 51(4): 978 - 982.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Rambold, C. Helmchen, A. Straube, and U. Buttner
Seesaw nystagmus associated with involuntary torsional head oscillations
Neurology, September 1, 1998; 51(3): 831 - 837.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Kumar, A. M. Lozano, Y. J. Kim, W. D. Hutchison, E. Sime, E. Halket, and A. E. Lang
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease
Neurology, September 1, 1998; 51(3): 850 - 855.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. P. Richardson, M. J. Koepp, D. J. Brooks, and J. S. Duncan
11C-flumazenil PET in neocortical epilepsy
Neurology, August 1, 1998; 51(2): 485 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
F. Pozo, I. Casas, A. Tenorio, G. Trallero, and J. M. Echevarria
Evaluation of a Commercially Available Reverse Transcription-PCR Assay for Diagnosis of Enteroviral Infection in Archival and Prospectively Collected Cerebrospinal Fluid Specimens
J. Clin. Microbiol., June 1, 1998; 36(6): 1741 - 1745.
[Abstract] [Full Text]


Home page
NeurologyHome page
Y. Miki, R. I. Grossman, J. K. Udupa, L. Wei, D. L. Kolson, L. J. Mannon, and M. Grossman
Isolated U-fiber involvement in MS: Preliminary observations
Neurology, May 1, 1998; 50(5): 1301 - 1306.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. Serles, E. Pataraia, J. Bacher, A. Olbrich, S. Aull, J. Lehrner, F. Leutmezer, L. Deecke, and C. Baumgartner
Clinical seizure lateralization in mesial temporal lobe epilepsy: Differences between patients with unitemporal and bitemporal interictal spikes
Neurology, March 1, 1998; 50(3): 742 - 747.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Spreafico, G. Battaglia, P. Arcelli, F. Andermann, F. Dubeau, A. Palmini, A. Olivier, J.-G. Villemure, D. Tampieri, G. Avanzini, et al.
Cortical dysplasia: An immunocytochemical study of three patients
Neurology, January 1, 1998; 50(1): 27 - 36.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. C. Gorson, A. H. Ropper, B. D. Clark, R. B. Dew III, D. Simovic, and G. Allam
Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-{alpha} 2a
Neurology, January 1, 1998; 50(1): 84 - 87.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Venneri and P. Caffarra
Transient autobiographic amnesia: EEG and single-photon emission CT evidence of an organic etiology
Neurology, January 1, 1998; 50(1): 186 - 191.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Silvestrini, E. Troisi, M. Matteis, C. Razzano, and C. Caltagirone
Correlations of flow velocity changes during mental activity and recovery from aphasia in ischemic stroke
Neurology, January 1, 1998; 50(1): 191 - 195.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Filippi, M. L. Gawne-Cain, C. Gasperini, J. H. vanWaesberghe, J. Grimaud, F. Barkhof, M. P. Sormani, and D. H. Miller
Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis
Neurology, January 1, 1998; 50(1): 238 - 244.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
G. Stevanin, A. Durr, G. David, O. Didierjean, G. Cancel, S. Rivaud, A. Tourbah, J.-M. Warter, Y. Agid, and A. Brice
Clinical and molecular features of spinocerebellar ataxia type 6
Neurology, November 1, 1997; 49(5): 1243 - 1246.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. F. Bucher, M. Dieterich, K. C. Seelos, and T. Brandt
Sensorimotor cerebral activation during optokinetic nystagmus: A functional MRI study
Neurology, November 1, 1997; 49(5): 1370 - 1377.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. Godefroy and M. Rousseaux
Novel decision making in patients with prefrontal or posterior brain damage
Neurology, September 1, 1997; 49(3): 695 - 701.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. J. Koepp, M. P. Richardson, C. Labbe, D. J. Brooks, V. J. Cunningham, J. Ashburner, W. Van Paesschen, T. Revesz, and J. S. Duncan
11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy
Neurology, September 1, 1997; 49(3): 764 - 773.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Filippi, J. H. van Waesberghe, M. A. Horsfield, S. Bressi, C. Gasperini, T. A. Yousry, M. L. Gawne-Cain, S. P. Morrissey, M. A. Rocca, F. Barkhof, et al.
Interscanner variation in brain MRI lesion load measurements in MS: Implications for clinical trials
Neurology, August 1, 1997; 49(2): 371 - 377.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M.-M. Mesulam, N. Johnson, Z. Grujic, and S. Weintraub
Apolipoprotein E genotypes in primary progressive aphasia
Neurology, July 1, 1997; 49(1): 51 - 55.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Filippi, N. Marciano, R. Capra, M. A. Rocca, F. Prandini, R. Gasparotti, M. A. Horsfield, and G. Comi
The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis
Neurology, July 1, 1997; 49(1): 274 - 276.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. E. Moulin, N. Hagen, T. E. Feasby, R. Amireh, and A. Hahn
Pain in Guillain-Barre syndrome
Neurology, February 1, 1997; 48(2): 328 - 331.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. P. Urban, H. C. Hopf, P. G. Zorowka, S. Fleischer, and J. Andreas
Dysarthria and lacunar stroke: Pathophysiologic aspects
Neurology, November 1, 1996; 47(5): 1135 - 1141.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.